Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies and Fc fusion protein modifications with enhanced persistence or pharmacokinetic stability in vivo and methods of use thereof

Antibodies and Fc fusion protein modifications with enhanced persistence or pharmacokinetic stability in vivo and methods of use thereof

US Patent 11136377 · Granted Oct 5, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Humanized mouse models of the FcRn recycling pathway2024
Humanized affinity matured anti-FcRn antibodies2020
Humanized affinity matured anti-FcRn antibodies2020
Antibodies and FC fusion protein modifications with enhanced persistence or phar2019
Antibodies and FC fusion protein modifications with enhanced persistence or phar2019
Systems and methods for statistical genomic DNA based analysis and evaluation2011
Expression data analysis systems and methods2010
Transgenic mouse expressing human FcRn protein2008
FcRn-based therapeutics for the treatment of auto-immune disorders2006